TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus (Q44786845)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

6 December 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus (English)

1 reference

6 December 2017

0 references

Wataru Matsuyama

1

1 reference

6 December 2017

Masuki Yamamoto

2

1 reference

6 December 2017

Ikkou Higashimoto

3

1 reference

6 December 2017

Ken-ichi Oonakahara

4

1 reference

6 December 2017

Masaki Watanabe

5

1 reference

6 December 2017

Kentarou Machida

6

1 reference

6 December 2017

Teizo Yoshimura

7

1 reference

6 December 2017

Nobutaka Eiraku

8

1 reference

6 December 2017

Masaharu Kawabata

9

1 reference

6 December 2017

Mitsuhiro Osame

10

1 reference

6 December 2017

Kimiyoshi Arimura

11

1 reference

6 December 2017

language of work or name

English

0 references

publication date

4 March 2004

1 reference

6 December 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

Blood

1 reference

6 December 2017

104

1 reference

6 December 2017

1

1 reference

6 December 2017

184-191

1 reference

Activation of discoidin domain receptor 1 facilitates the maturation of human monocyte-derived dendritic cells through the TNF receptor associated factor 6/TGF-beta-activated protein kinase 1 binding protein 1 beta/p38 alpha mitogen-activated protei

6 December 2017

2 references

https://opencitations.net/index/api/v1/citations/10.4049/JIMMUNOL.171.7.3520

COCI

reference URL

30 December 2023

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Interaction of discoidin domain receptor 1 isoform b (DDR1b) with collagen activates p38 mitogen-activated protein kinase and promotes differentiation of macrophages

2 references

https://opencitations.net/index/api/v1/citations/10.1096/FJ.02-0320FJE

COCI

reference URL

30 December 2023

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

The receptor for the cytotoxic ligand TRAIL

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

The neutrophil as a cellular source of chemokines

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Acute and chronic neutropenias. What is new?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Acceleration of human neutrophil apoptosis by TRAIL.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Antineutrophil cytoplasmic antibodies induce reactive oxygen-dependent dysregulation of primed neutrophil apoptosis and clearance by macrophages

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD)

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Role of TRAIL and IFN-gamma in CD4+ T cell-dependent tumor rejection in the anterior chamber of the eye.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Induction of biologically active antineutrophil cytoplasmic antibodies by immunization with human apoptotic polymorphonuclear leukocytes

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Anti-SSB/La is one of the antineutrophil autoantibodies responsible for neutropenia and functional impairment of polymorphonuclear neutrophils in patients with systemic lupus erythematosus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Low Fcgamma receptor III and high granulocyte colony-stimulating factor serum levels correlate with the risk of infection in neutropenia due to Felty's syndrome or systemic lupus erythematosus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Defective phagocytosis, decreased tumour necrosis factor-alpha production, and lymphocyte hyporesponsiveness predispose patients with systemic lupus erythematosus to infections

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Hematologic aspects of systemic lupus erythematosus. Current concepts

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

The role of apoptosis-inducing receptors of the tumor necrosis factor family in thyroid cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Idiopathic, immune, infectious, and idiosyncratic neutropenias

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Reduction of phagocytosis and lysosomal enzyme release from human leukocytes by serum from patients with systemic lupus erythematosus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

A novel receptor for Apo2L/TRAIL contains a truncated death domain

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Anti-granulocyte opsonic activity in sera from patients with systemic lupus erythematosus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Treatment of lupus with corticosteroids

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Incidence of infection in systemic lupus erythematosus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

NA-phenotype-dependent differences in neutrophil Fc gamma RIIIb expression cause differences in plasma levels of soluble Fc gamma RIII

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Dexamethasone inhibits apoptosis of human neutrophils induced by reactive oxygen species

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

IFN-gamma inhibition of TRAIL-induced IAP-2 upregulation, a possible mechanism of IFN-gamma-enhanced TRAIL-induced apoptosis.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1182/BLOOD-2003-12-4274

Identifiers

DOI

10.1182/BLOOD-2003-12-4274

1 reference

6 December 2017

1 reference